Open AccessTelehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic
Author(s) -
Jennifer A Sculley,
Hugh Musick,
Jerry A. Krishnan
Publication year - 2021
Publication title -
current opinion in pulmonary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.937
H-Index - 75
eISSN - 1531-6971
pISSN - 1070-5287
DOI - 10.1097/mcp.0000000000000851
Subject(s) - telehealth , medicine , pandemic , reimbursement , copd , psychological intervention , health care , telemedicine , randomized controlled trial , disease , medline , family medicine , medical emergency , intensive care medicine , covid-19 , nursing , infectious disease (medical specialty) , economics , economic growth , political science , law
Many healthcare systems rapidly implemented telehealth as a substitute for in-person care during the coronavirus disease 2019 (COVID-19) pandemic. The purpose of this review is to describe the evidence base supporting the use of telehealth for chronic obstructive pulmonary disease (COPD) prior to the COVID-19 pandemic, discuss the barriers to implementing telehealth during the pandemic, and share our opinion about the future of telehealth in COPD.